BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 19345670)

  • 1. The juxtamembrane domain in ETV6/FLT3 is critical for PIM-1 up-regulation and cell proliferation.
    Vu HA; Xinh PT; Kano Y; Tokunaga K; Sato Y
    Biochem Biophys Res Commun; 2009 Jun; 383(3):308-13. PubMed ID: 19345670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constitutively activated FLT3 phosphorylates BAD partially through pim-1.
    Kim KT; Levis M; Small D
    Br J Haematol; 2006 Sep; 134(5):500-9. PubMed ID: 16869825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tel/PDGFRbeta induces stem cell differentiation via the Ras/ERK and STAT5 signaling pathways.
    Dobbin E; Graham C; Corrigan PM; Thomas KG; Freeburn RW; Wheadon H
    Exp Hematol; 2009 Jan; 37(1):111-121. PubMed ID: 19100521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transformation by oncogenic mutants and ligand-dependent activation of FLT3 wild-type requires the tyrosine residues 589 and 591.
    Vempati S; Reindl C; Wolf U; Kern R; Petropoulos K; Naidu VM; Buske C; Hiddemann W; Kohl TM; Spiekermann K
    Clin Cancer Res; 2008 Jul; 14(14):4437-45. PubMed ID: 18628457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ETV6/FLT3 Fusion Is a Novel Client Protein of Hsp90.
    Ly BTK; Chi HT
    Oncol Res; 2018 Sep; 26(8):1201-1205. PubMed ID: 29471895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FLT3 is fused to ETV6 in a myeloproliferative disorder with hypereosinophilia and a t(12;13)(p13;q12) translocation.
    Vu HA; Xinh PT; Masuda M; Motoji T; Toyoda A; Sakaki Y; Tokunaga K; Sato Y
    Leukemia; 2006 Aug; 20(8):1414-21. PubMed ID: 16761019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mislocalized activation of oncogenic RTKs switches downstream signaling outcomes.
    Choudhary C; Olsen JV; Brandts C; Cox J; Reddy PN; Böhmer FD; Gerke V; Schmidt-Arras DE; Berdel WE; Müller-Tidow C; Mann M; Serve H
    Mol Cell; 2009 Oct; 36(2):326-39. PubMed ID: 19854140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MS-275, a novel histone deacetylase inhibitor with selectivity against HDAC1, induces degradation of FLT3 via inhibition of chaperone function of heat shock protein 90 in AML cells.
    Nishioka C; Ikezoe T; Yang J; Takeuchi S; Koeffler HP; Yokoyama A
    Leuk Res; 2008 Sep; 32(9):1382-92. PubMed ID: 18394702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ETV6: a versatile player in leukemogenesis.
    Bohlander SK
    Semin Cancer Biol; 2005 Jun; 15(3):162-74. PubMed ID: 15826831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role of Gab2 association in Flt3 ITD mediated Stat5 phosphorylation and cell survival.
    Masson K; Liu T; Khan R; Sun J; Rönnstrand L
    Br J Haematol; 2009 Jul; 146(2):193-202. PubMed ID: 19438505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutive Fms-like tyrosine kinase 3 activation results in specific changes in gene expression in myeloid leukaemic cells.
    Kim KT; Baird K; Davis S; Piloto O; Levis M; Li L; Chen P; Meltzer P; Small D
    Br J Haematol; 2007 Sep; 138(5):603-15. PubMed ID: 17686054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pim-1 kinase phosphorylates and stabilizes 130 kDa FLT3 and promotes aberrant STAT5 signaling in acute myeloid leukemia with FLT3 internal tandem duplication.
    Natarajan K; Xie Y; Burcu M; Linn DE; Qiu Y; Baer MR
    PLoS One; 2013; 8(9):e74653. PubMed ID: 24040307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transformation of Ba/F3 cells and Rat-1 cells by ETV6/ARG.
    Iijima Y; Okuda K; Tojo A; Tri NK; Setoyama M; Sakaki Y; Asano S; Tokunaga K; Kruh GD; Sato Y
    Oncogene; 2002 Jun; 21(28):4374-83. PubMed ID: 12080468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the SAM domain of the ETV6-NTRK3 chimeric tyrosine kinase block polymerization and transformation activity.
    Tognon CE; Mackereth CD; Somasiri AM; McIntosh LP; Sorensen PH
    Mol Cell Biol; 2004 Jun; 24(11):4636-50. PubMed ID: 15143160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multistep pathogenesis of leukemia via the MLL-AF4 chimeric gene/Flt3 gene tyrosine kinase domain (TKD) mutation-related enhancement of S100A6 expression.
    Yamaguchi H; Hanawa H; Uchida N; Inamai M; Sawaguchi K; Mitamura Y; Shimada T; Dan K; Inokuchi K
    Exp Hematol; 2009 Jun; 37(6):701-14. PubMed ID: 19463771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A constitutively active SPTBN1-FLT3 fusion in atypical chronic myeloid leukemia is sensitive to tyrosine kinase inhibitors and immunotherapy.
    Grand FH; Iqbal S; Zhang L; Russell NH; Chase A; Cross NC
    Exp Hematol; 2007 Nov; 35(11):1723-7. PubMed ID: 17764812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ETV6/ARG oncoprotein confers autonomous cell growth by enhancing c-Myc expression via signal transducer and activator of transcription 5 activation in the acute promyelocytic leukemia cell line HT93A.
    Iriyama N; Hatta Y; Takei M
    Leuk Lymphoma; 2015; 56(8):2416-23. PubMed ID: 25373509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the nuclear localization motif in the ETV6 (TEL) protein.
    Park H; Seo Y; Kim JI; Kim WJ; Choe SY
    Cancer Genet Cytogenet; 2006 Jun; 167(2):117-21. PubMed ID: 16737910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression cloning of oligomerization-activated genes with cell-proliferating potency by pseudotype retrovirus vector.
    Abe A; Emi N; Kanie T; Imagama S; Kuno Y; Takahashi M; Saito H; Naoe T
    Biochem Biophys Res Commun; 2004 Jul; 320(3):920-6. PubMed ID: 15240136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ETV6 fusion genes in hematological malignancies: a review.
    De Braekeleer E; Douet-Guilbert N; Morel F; Le Bris MJ; Basinko A; De Braekeleer M
    Leuk Res; 2012 Aug; 36(8):945-61. PubMed ID: 22578774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.